Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Personalized Medicine|November 26, 2025
Identification of Chemotherapy-Induced Peripheral Neuropathy-A Self-Administered Scoring System Tested in Breast Cancer Survivors: Protocol of the NEURO-BREAC TrialDirk Rades, Maria Karolin Streubel, Laura Doehring, et al.In Vivo (Athens, Greece)|June 30, 2026
Course of Step Counts During Systemic Treatment for Non-small Cell Lung Cancer-Observational Data from a Prematurely Terminated Prospective StudyDirk Rades, Maria K Streubel, Laura Doehring, et al.Anticancer Research|June 29, 2026
Physical Activity During Radiotherapy for Lung Cancer - Evaluating Functionality and Practicability of a Reminder App in Healthy VolunteersMaria K Streubel, Laura Doehring, Hanne Falk Grauslund, et al.In Vivo (Athens, Greece)|August 28, 2025
Risk Factors for Radiation Pneumonitis and a Prognostic Instrument for Very Elderly Patients With Lung CancerDirk Rades, Cansu Delikanli, Laura Doehring, et al.In Vivo (Athens, Greece)|June 27, 2025
Frequency and Risk Factors of Inappropriate Bladder Filling in Patients Irradiated for High-risk Prostate CancerDirk Rades, Laura Doehring, Jan-Dirk Küter, et al.Anticancer Research|August 1, 2025
Estimating the Risk of Radiation Pneumonitis in Elderly Patients With Lung CancerDirk Rades, Laura Doehring, Cansu Delikanli, et al.Clinics and Practice|August 27, 2025
Assessment of Physical Activity During Chemotherapy and/or Immunotherapy for Non-Small Cell Lung Cancer (NSCLC): Protocol of the APACHIE-01 StudyDirk Rades, Laura Doehring, Christian Staackmann, et al.Anticancer Research|May 27, 2026
Standard Clinical Characteristics Fail to Predict Mild Chemotherapy-induced Peripheral Neuropathy in Breast Cancer PatientsDirk Rades, Maria K Streubel, Christian Staackmann, et al.In Vivo (Athens, Greece)|April 28, 2026
Does Irradiation of Pelvic Lymph Nodes Have an Impact on the Bladder Filling Status in Patients With High-risk Prostate Cancer?Dirk Rades, Laura Doehring, Jan-Dirk Küter, et al.Cancers|March 14, 2026
A New Scoring System Administered by Patients to Identify Moderate-to-Severe Chemotherapy-Induced Peripheral Neuropathy: Final Results of the NEURO-BREAC TrialDirk Rades, Maria Karolin Streubel, Christian Staackmann, et al.Pageof 2